TRCT
ZEPP

Tower Research Capital (TRC)’s Zepp Health ZEPP Stock Holding History

Tower Research Capital (TRC)’s Portfolio ZEPP Stock Details ZEPP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.82K Sell
734
-1,839
-71% -$19.2K ﹤0.01% 4466
2026
Q1 		$30.7K Buy
2,573
+2,198
+586% +$45K ﹤0.01% 3147
2025
Q4 		$10.1K Sell
375
-249
-40% -$8.88K ﹤0.01% 3834
2025
Q3 		$28.6K Buy
+624
New +$18.9K ﹤0.01% 2984
2023
Q3 		– Sell
-584
Closed -$2.66K – 6289
2023
Q2 		$2.66K Buy
584
+256
+78% +$1.29K ﹤0.01% 5171
2023
Q1 		$2K Buy
328
+303
+1,212% +$2.15K ﹤0.01% 5414
2022
Q4 		$0 Buy
+25
New +$134 ﹤0.01% 6464
2022
Q3 		– Sell
-2,212
Closed -$16K – 6556
2022
Q2 		$16K Buy
2,212
+1,570
+245% +$14.5K ﹤0.01% 4032
2022
Q1 		$7K Buy
642
+217
+51% +$3.5K ﹤0.01% 4778
2021
Q4 		$9K Sell
425
-814
-66% -$24.4K ﹤0.01% 4736
2021
Q3 		$39K Buy
1,239
+1,085
+705% +$44.8K ﹤0.01% 3161
2021
Q2 		$8K Sell
154
-376
-71% -$15.7K ﹤0.01% 4514
2021
Q1 		$23K Buy
530
+377
+246% +$21.9K ﹤0.01% 3786
2020
Q4 		$7K Buy
+153
New +$7.63K ﹤0.01% 4508
2020
Q3 		– Sell
-201
Closed -$10K – 5146
2020
Q2 		$10K Sell
201
-755
-79% -$34.8K ﹤0.01% 4024
2020
Q1 		$51K Buy
+956
New +$51.7K ﹤0.01% 1290
2019
Q4 		– Sell
-423
Closed -$17K – 4488
2019
Q3 		$17K Buy
+423
New +$17.8K ﹤0.01% 2581
2019
Q2 		– Sell
-145
Closed -$8K – 4396
2019
Q1 		$8K Buy
145
+51
+54% +$2.75K ﹤0.01% 2829
2018
Q4 		$4K Buy
+94
New +$3.69K ﹤0.01% 3084

Other funds holding ZEPP

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
YCM
Yiheng Capital Management San Francisco, California $291M AUM 19.43% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Mirae Asset Global ETFs Holdings
Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $83.9B AUM 60.43% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Tower Research Capital (TRC)'s ZEPP Position: Q2 2026 in Review

Tower Research Capital (TRC) reduced its Zepp Health (ZEPP) stake by 71% in Q2 2026, selling an estimated $19.2K and leaving 734 shares worth $3.82K. The position accounts for ﹤0.01% of the portfolio, ranked #4466.

Tower Research Capital (TRC) first reported a position in ZEPP in Q4 2018 and has held it in 19 quarters since. The position peaked at $51K in Q1 2020. 28 funds tracked by Wall St. Rank hold ZEPP as of Q2 2026.

  • Tower Research Capital (TRC) held 734 shares of Zepp Health worth $3.82K as of Q2 2026.
  • Tower Research Capital (TRC) sold 1,839 Zepp Health shares in Q2 2026, an estimated $19.2K.
  • Zepp Health made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #4466 holding.
  • Tower Research Capital (TRC) first reported a position in Zepp Health in Q4 2018 and has held it in 19 quarters since.
  • Tower Research Capital (TRC)'s Zepp Health position peaked at $51K in Q1 2020.
  • 28 funds tracked by Wall St. Rank held Zepp Health as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.